Veerapol Kukongviriyapan

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Oxidative Stress

Cell Proliferation

Top Venues

Asian Pacific journal of cancer prevention : APJCP

Naunyn-Schmiedeberg's archives of pharmacology

The Journal of pharmacy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Laddawan Senggunprai, Veerapol Kukongviriyapan, Auemduan Prawan, Sarinya Kongpetch
Epidermal growth factor receptor as a potential target of momordin Ic to promote apoptosis of cholangiocarcinoma cells. The Journal of pharmacy and pharmacology 74 (7) (2022)
Phatthamon Laphanuwat, Sarinya Kongpetch, Laddawan Senggunprai, Auemduan Prawan, Veerapol Kukongviriyapan
Licochalcone A Induces Cholangiocarcinoma Cell Death Via Suppression of Nrf2 and NF-κB Signaling Pathways. Asian Pacific journal of cancer prevention : APJCP 23 (1) (2022)
Putthaporn Kaewmeesri, Veerapol Kukongviriyapan, Auemduan Prawan, Sarinya Kongpetch, Laddawan Senggunprai
Cucurbitacin B Diminishes Metastatic Behavior of Cholangiocarcinoma Cells by Suppressing Focal Adhesion Kinase. Asian Pacific journal of cancer prevention : APJCP 22 (1) (2021)
Papavee Samatiwat, Lueacha Tabtimmai, Prapasiri Suphakun, Nattanan Jiwacharoenchai, Borvorrnvat Toviwek, Veerapol Kukongviriyapan, Matthew Paul Gleeson, Kiattawee Choowongkomon
The Effect of the EGFR - Targeting Compound 3-[(4-Phenylpyrimidin-2-yl) Amino] Benzene-1-Sulfonamide (13f) against Cholangiocarcinoma Cell Lines. Asian Pacific journal of cancer prevention : APJCP 22 (2) (2021)
Jaroon Wandee, Piyarat Srinontong, Auemduan Prawan, Laddawan Senggunprai, Sarinya Kongpetch, Chavi Yenjai, Veerapol Kukongviriyapan
Derrischalcone suppresses cholangiocarcinoma cells through targeting ROS-mediated mitochondrial cell death, Akt/mTOR, and FAK pathways. Naunyn-Schmiedeberg's archives of pharmacology 394 (9) (2021)
Rattanaporn Jaidee, Sarinya Kongpetch, Laddawan Senggunprai, Auemduan Prawan, Upa Kukongviriyapan, Veerapol Kukongviriyapan
Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways. Naunyn-Schmiedeberg's archives of pharmacology 393 (9) (2020)